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tumor. Attempts of developing tumor targeting drug, which 
would be capable to deliver necessary amount of high atomic 
number element into the tumor haven’t succeed yet. Another 
possible way to deliver such elements into the tumor is to 
utilize some pathological processes caused by tumorogenesis 
such as blood barrier disruption in case of brain tumors or 
high vascularization inherent to some tumors. In this work 
the efficacy of x-rays irradiation with disodium 
gadopentetate (Gd-DTPA) administration in treating highly 
vascularized transplanted tumor in mice was studied. 
 
Material and Methods: C57Bl/6 mice with transplanted 
adencarcinoma Ca755 were used in the study. Animals were 
divided into three groups. 1st group undergo no treatment. 
2nd group was irradiated with 10 Gy of x-rays. Animals in 3rd 
group were administered with 0.3 ml of 0.5M water solution 
of Gd-DTPA, containing 23 mg of gadolinium and then 
irradiated as well. Administration of Gd-DTPA was performed 
with single systemic injection. Irradiation was performed 
using x-rays generator with anode voltage of 200 kV. 
Antineoplastic efficacy was estimated by measuring tumor 
volume and life span of mice. 
 
Results: Tumor growth rate plots are presented in Figure. 
 
Tumor growth delay for test group was 13 days whereas in 
irradiated control group tumor growth delay was just 4 days. 
Median life span was 22 days, 37 days and 46 days for control 
group, irradiated control group and test group respectively. 
In test group 25% of animals have full tumor regression 
whereas in both control groups no tumor regression was 
observed. Endpoints of antitumor evaluation, i.e. T/C% ratio 
and gross log10 tumor cell kill are represented in Table. 
 
 
 
Conclusion: Obtained results show that systemic injection of 
extracellular drug with gadolinium prior irradiation with x-
rays provide enough amount of gadolinium in highly 
vascularized tumors and lead to significant increase of 
antineoplastic efficacy of x-rays irradiation. 
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Purpose or Objective: With the development of molecular 
biology and gene engineering，more and more attention has 
been paid to gene-radiotherapy of malignant tumors. The 
combination of gene therapy and radiotherapy is regarded as 
one of the effective methods for the treatment of tumors. 
This research focused on the Egr-1 promoter with radiation-
induced effect, p53 and endostatin genes with function of 
inducing apoptosis and anti-angiogenesis, and EGFR-targeted 
adenovirus vector with higher cell infection efficiency. The 
therapeutic effect of adenovirus vectors Ad.Egr-wtp53-
endostatin and Ad.CMV-sCAR-EGF combined with 
radiotherapy in non-small cell lung cancer is here reported.  
 
Material and Methods: The adenovirus vectors Ad.Egr-wtp53-
endostatin containing both wild type p53 and antiangiogenic 
molecule endostatin genes downstream of early growth 
response-1 (Egr-1) and Ad.CMV-sCAR-EGF containing 
coxsackie virus receptor extracellular segment (sCAR) and 
epidermal growth factor (EGF) were constructed using gene 
recombination technique. The infection efficiency in non-
small cell lung cancer cell lines (A549, LK-2 and Lu65) of 
Ad.Egr-wtp53-endostatin mediated with Ad.CMV-sCAR-EGF 
expressed fusion protein sCAR-EGF was detected. The 
expression of wild type p53 and endostatin genes by the 
radiation-sensitive promoter Egr-1 in non-small cell lung 
cancer cell lines were observed. Immunodeficient mice 
(NOD/scid) subcutaneously implanted with A549 cells were 
treated by conventional radiotherapy (2Gy×6) and/or gene 
therapy (intratumor injection of adenovirus vectors Ad.Egr-
wtp53-endostatin and Ad.CMV-sCAR-EGF 24 h before the first 
and fourth local doses). Immunologic mechanisms were 
explored. 
 
Results: The fusion protein SCAR-EGF expressed from 
Ad.CMV-sCAR-EGF significantly increased infection efficiency 
of Ad.Egr-wtp53-endostatin in human non-small cell lung 
cancer cell lines. Cancer control was most significantly 
improved in the group receiving local radiotherapy combined 
with gene therapy as shown by prolongation of mean survival 
time by 75.2%, reduction in average tumor weight by 88.7%, 
decrease in pulmonary metastasis by 76.9% and decrease in 
intratumor angiogenesis by 80.4% as compared to local 
radiotherapy alone (P < 0.05). Immunologic studies showed 
stimulated natural killer (NK) and cytotoxic T lymphocyte 
(CTL) activity as well as increased interferon-γ (IFN- γ) and 
tumor necrosis factor-α (TNF-α) secretion in this combined 
treatment group as compared with the group receiving local 
treatment alone (P < 0.05). 
 
Conclusion: The experimental findings in the present study 
showed that adenovirus vectors Ad.Egr-wtp53-endostatin and 
Ad.CMV-sCAR-EGF in combination with local radiotherapy 
could improve the tumor control. These observations may set 
the stage for developing clinical protocols with recombinant 
adenovirus-mediated gene-radiotherapy in non-small cell lung 
cancer. 
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Purpose or Objective: One of the main effects of 
radiotherapy is the generation of free radicals as a 
consequence of the incidence of radiation on the aqueous 
molecules present in the cells. The enzyme D-aminoacid 
oxidase (DAO) is also able to generate free radicals when 
converting D-aminoacids in their corresponding cetoacids. 
Our principal aim is to increase radiotherapy effects, using 
